People on the Move
RRD International
Product development company RRD International has found a new Chief Financial Officer and Senior VP in Brian Gallagher.
Gallagher brings more than 20 years of financial experience from working in biopharma multinationals and commercial stage biotechs. He will replace Robert Smith who will retire at the end of the calendar year.
RRD gives pharma companies and investors support for strategy, regulations and operations.
RRD President Scott Tarrant said the company’s PDT (Product Development Team) model for working has been gaining traction among pharma companies because it minimises cost and time to reaching proof-of-concept stage:
"The attractiveness of the PDT model and dynamics of the macro business environment has put RRD on a significant growth track.”
Brian Gallagher's previous experience includes positions at Merck & Company, Therakos (part of J&J), and Adolor Corporation. Most recently, he was VP of Finance for Optimer Pharmaceuticals, where he played a significant role in the recent sale of the company to Cubist Pharmaceuticals for over $500 million.